AAM
Azzad Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-3,093
| Closed | -$1.97M | – | 372 |
|
2022
Q3 | $1.97M | Sell |
3,093
-2,000
| -39% | -$1.27M | 0.2% | 170 |
|
2022
Q2 | $3.09M | Buy |
5,093
+2,555
| +101% | +$1.55M | 0.31% | 112 |
|
2022
Q1 | $1.77M | Sell |
2,538
-789
| -24% | -$551K | 0.26% | 154 |
|
2021
Q4 | $2.1M | Buy |
3,327
+32
| +1% | +$20.2K | 0.28% | 140 |
|
2021
Q3 | $1.99M | Buy |
3,295
+74
| +2% | +$44.8K | 0.29% | 138 |
|
2021
Q2 | $1.8M | Sell |
3,221
-100
| -3% | -$55.9K | 0.27% | 155 |
|
2021
Q1 | $1.57M | Buy |
3,321
+233
| +8% | +$110K | 0.26% | 158 |
|
2020
Q4 | $1.49M | Sell |
3,088
-3
| -0.1% | -$1.45K | 0.27% | 147 |
|
2020
Q3 | $1.73M | Buy |
3,091
+567
| +22% | +$317K | 0.36% | 110 |
|
2020
Q2 | $1.57M | Sell |
2,524
-583
| -19% | -$364K | 0.37% | 97 |
|
2020
Q1 | $1.52M | Sell |
3,107
-2,437
| -44% | -$1.19M | 0.44% | 75 |
|
2019
Q4 | $2.71M | Buy |
5,544
+56
| +1% | +$27.4K | 0.32% | 108 |
|
2019
Q3 | $2.4M | Buy |
+5,488
| New | +$2.4M | 0.3% | 118 |
|
2017
Q2 | – | Sell |
-652
| Closed | -$253K | – | 305 |
|
2017
Q1 | $253K | Hold |
652
| – | – | 0.1% | 242 |
|
2016
Q4 | $239K | Hold |
652
| – | – | 0.1% | 225 |
|
2016
Q3 | $262K | Hold |
652
| – | – | 0.11% | 227 |
|
2016
Q2 | $228K | Hold |
652
| – | – | 0.1% | 231 |
|
2016
Q1 | $235K | Sell |
652
-1
| -0.2% | -$360 | 0.1% | 226 |
|
2015
Q4 | $354K | Sell |
653
-2
| -0.3% | -$1.09K | 0.17% | 193 |
|
2015
Q3 | $305K | Hold |
655
| – | – | 0.16% | 208 |
|
2015
Q2 | $334K | Sell |
655
-855
| -57% | -$436K | 0.17% | 211 |
|
2015
Q1 | $682K | Hold |
1,510
| – | – | 0.33% | 126 |
|
2014
Q4 | $620K | Sell |
1,510
-953
| -39% | -$391K | 0.33% | 123 |
|
2014
Q3 | $888K | Hold |
2,463
| – | – | 0.51% | 50 |
|
2014
Q2 | $696K | Sell |
2,463
-525
| -18% | -$148K | 0.42% | 98 |
|
2014
Q1 | $897K | Buy |
2,988
+37
| +1% | +$11.1K | 0.59% | 32 |
|
2013
Q4 | $812K | Buy |
2,951
+43
| +1% | +$11.8K | 0.59% | 44 |
|
2013
Q3 | $910K | Hold |
2,908
| – | – | 0.75% | 20 |
|
2013
Q2 | $694K | Buy |
+2,908
| New | +$694K | 0.6% | 42 |
|